SI3004388T2 - Odkrivanje in kvantifikacija donorjeve brezcelične DNK v cirkulaciji prejemnikov presajenih organov - Google Patents

Odkrivanje in kvantifikacija donorjeve brezcelične DNK v cirkulaciji prejemnikov presajenih organov

Info

Publication number
SI3004388T2
SI3004388T2 SI201431041T SI201431041T SI3004388T2 SI 3004388 T2 SI3004388 T2 SI 3004388T2 SI 201431041 T SI201431041 T SI 201431041T SI 201431041 T SI201431041 T SI 201431041T SI 3004388 T2 SI3004388 T2 SI 3004388T2
Authority
SI
Slovenia
Prior art keywords
quantification
circulation
detection
free dna
organ transplant
Prior art date
Application number
SI201431041T
Other languages
English (en)
Other versions
SI3004388T1 (sl
Inventor
Ekkehard Schutz
Julia Beck
Original Assignee
Chronix Biomedical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51989530&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI3004388(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chronix Biomedical filed Critical Chronix Biomedical
Publication of SI3004388T1 publication Critical patent/SI3004388T1/sl
Publication of SI3004388T2 publication Critical patent/SI3004388T2/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
    • G01N2800/245Transplantation related diseases, e.g. graft versus host disease
SI201431041T 2013-05-29 2014-05-29 Odkrivanje in kvantifikacija donorjeve brezcelične DNK v cirkulaciji prejemnikov presajenih organov SI3004388T2 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361828553P 2013-05-29 2013-05-29
PCT/US2014/040055 WO2014194113A2 (en) 2013-05-29 2014-05-29 Detection and quantification of donor cell-free dna in the circulation of organ transplant recipients
EP14804474.6A EP3004388B2 (en) 2013-05-29 2014-05-29 Detection and quantification of donor cell-free dna in the circulation of organ transplant recipients

Publications (2)

Publication Number Publication Date
SI3004388T1 SI3004388T1 (sl) 2019-03-29
SI3004388T2 true SI3004388T2 (sl) 2023-11-30

Family

ID=51989530

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201431041T SI3004388T2 (sl) 2013-05-29 2014-05-29 Odkrivanje in kvantifikacija donorjeve brezcelične DNK v cirkulaciji prejemnikov presajenih organov

Country Status (12)

Country Link
US (3) US20160115541A1 (sl)
EP (1) EP3004388B2 (sl)
CY (1) CY1122332T1 (sl)
DK (1) DK3004388T4 (sl)
ES (1) ES2704682T5 (sl)
HR (1) HRP20190209T4 (sl)
HU (1) HUE041935T2 (sl)
LT (1) LT3004388T (sl)
PL (1) PL3004388T5 (sl)
PT (1) PT3004388T (sl)
SI (1) SI3004388T2 (sl)
WO (1) WO2014194113A2 (sl)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
AU2011255641A1 (en) 2010-05-18 2012-12-06 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
CA3209140A1 (en) 2012-04-19 2013-10-24 The Medical College Of Wisconsin, Inc. Highly sensitive surveillance using detection of cell free dna
CN113528645A (zh) 2014-03-14 2021-10-22 凯尔迪克斯公司 用于在移植受体中监测免疫抑制疗法的方法
RU2717641C2 (ru) 2014-04-21 2020-03-24 Натера, Инк. Обнаружение мутаций и плоидности в хромосомных сегментах
EP4358097A1 (en) 2014-07-25 2024-04-24 University of Washington Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same
WO2016123698A1 (en) * 2015-02-06 2016-08-11 Uti Limited Partnership Diagnostic assay for post-transplant assessment of potential rejection of donor organs
KR101850437B1 (ko) * 2015-04-14 2018-04-20 이원다이애그노믹스(주) 차세대 염기서열 분석기법을 이용한 장기 이식 거부 반응 예측 방법
JP2018514219A (ja) * 2015-04-30 2018-06-07 メディカル カレッジ オブ ウィスコンシン インコーポレイテッド 無細胞dnaを評価するための多重/最適化ミスマッチ増幅(moma)−リアルタイムpcr
WO2016183106A1 (en) 2015-05-11 2016-11-17 Natera, Inc. Methods and compositions for determining ploidy
CN106544407B (zh) * 2015-09-18 2019-11-08 广州华大基因医学检验所有限公司 确定受体cfDNA样本中供体来源cfDNA比例的方法
BR112018072196A2 (pt) * 2016-04-29 2019-02-12 Medical College Wisconsin Inc amplificação de incompatibilidade otimizada multiplexadas (moma) - número do alvo
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
CN110177874A (zh) * 2016-11-02 2019-08-27 威斯康星州立大学医学院 用于使用错配扩增和统计方法来评估风险的方法
EP3535413A1 (en) * 2016-11-02 2019-09-11 The Medical College of Wisconsin, Inc. Methods for assessing risk using total and specific cell-free dna
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
CA3067635A1 (en) * 2017-06-20 2018-12-27 The Medical College Of Wisconsin, Inc. Transplant patient monitoring with cell-free dna
EP3642353A4 (en) 2017-06-20 2021-02-24 The Medical College of Wisconsin, Inc. ASSESSMENT OF THE RISK OF COMPLICATION OF A TRANSPLANT WITH TOTAL ACELLULAR DNA
WO2019014667A1 (en) 2017-07-14 2019-01-17 The Regents Of The University Of California NEW METHODS FOR PREDICTING THE RISK OF GRAFT REJECTION
CA3085933A1 (en) * 2017-12-14 2019-06-20 Tai Diagnostics, Inc. Assessing graft suitability for transplantation
CA3085565A1 (en) 2017-12-15 2019-06-20 Acrannolife Genomics Pvt. Ltd. A non-invasive method for monitoring transplanted organ status in organ-transplant recipients
EP3517629A1 (en) 2018-01-30 2019-07-31 Myway Genetics S.r.L. Use of cfdna fragments as biomarkers in patients after organ transplantation
US11525159B2 (en) 2018-07-03 2022-12-13 Natera, Inc. Methods for detection of donor-derived cell-free DNA
US20200109449A1 (en) * 2018-10-09 2020-04-09 Tai Diagnostics, Inc. Cell lysis assay for cell-free dna analysis
US20220073989A1 (en) * 2018-12-20 2022-03-10 The Regents Of The University Of California Optimizing Detection of Transplant Injury by Donor-Derived Cell-Free DNA
US11931674B2 (en) 2019-04-04 2024-03-19 Natera, Inc. Materials and methods for processing blood samples
CN114645077A (zh) * 2020-12-17 2022-06-21 厦门大学 一种检测受体样品中供体的存在或比例的方法和试剂盒
CN113061666A (zh) * 2020-12-30 2021-07-02 中南大学湘雅二医院 肝移植后巨细胞病毒的检测方法、应用及系统
WO2023116717A1 (en) * 2021-12-22 2023-06-29 The First Affiliated Hospital Of Guangzhou Medical University Method for monitoring donar dna fraction
CN114381511A (zh) * 2021-12-31 2022-04-22 上海药明奥测医疗科技有限公司 一种评估肝移植术后移植物损伤及排斥风险的检测方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001050A1 (en) 1987-07-31 1989-02-09 The Board Of Trustees Of The Leland Stanford Junior University Selective amplification of target polynucleotide sequences
CA1340807C (en) 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5955589A (en) 1991-12-24 1999-09-21 Isis Pharmaceuticals Inc. Gapped 2' modified oligonucleotides
IL100040A (en) 1990-11-13 1995-12-31 Siska Diagnostics Inc Amplification of nucleic acids by replicating a self-sustaining enzymatic sequence
YU187991A (sh) 1990-12-11 1994-09-09 Hoechst Aktiengesellschaft 3-(2)-amino-ali tiol-modifikovani, s fluorescentnom bojom vezani nukleozidi, nukleotidi i oligonukleotidi, postupak za njihovo dobijanje i njihova upotreba
US5455166A (en) 1991-01-31 1995-10-03 Becton, Dickinson And Company Strand displacement amplification
US5652099A (en) 1992-02-12 1997-07-29 Conrad; Michael J. Probes comprising fluorescent nucleosides and uses thereof
US5446137B1 (en) 1993-12-09 1998-10-06 Behringwerke Ag Oligonucleotides containing 4'-substituted nucleotides
DE4415370A1 (de) 1994-05-02 1995-11-09 Hoechst Ag Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung
DE4438918A1 (de) 1994-11-04 1996-05-09 Hoechst Ag Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung
DK0866071T3 (da) 1997-03-20 2005-01-17 Hoffmann La Roche Modificerede primere
US6440706B1 (en) 1999-08-02 2002-08-27 Johns Hopkins University Digital amplification
DE60123448T2 (de) * 2001-12-24 2007-08-23 Prof. Wolfgang Holzgreve Verfahren zur nicht-invasiven Diagnose von Transplantationen und Transfusionen
WO2008098142A2 (en) 2007-02-08 2008-08-14 Sequenom, Inc. Nucleic acid-based tests for rhd typing, gender determination and nucleic acid quantification
WO2008118988A1 (en) 2007-03-26 2008-10-02 Sequenom, Inc. Restriction endonuclease enhanced polymorphic sequence detection
EP2193368A1 (en) * 2007-09-28 2010-06-09 Stryker Corporation Methods for detecting neutralizing antibodies for bone morphogenetic proteins
US20120034603A1 (en) * 2010-08-06 2012-02-09 Tandem Diagnostics, Inc. Ligation-based detection of genetic variants
WO2012115851A1 (en) 2011-02-22 2012-08-30 City Of Hope Ultra-high sensitive monitoring of early transplantation failure
CA3209140A1 (en) 2012-04-19 2013-10-24 The Medical College Of Wisconsin, Inc. Highly sensitive surveillance using detection of cell free dna
CN113528645A (zh) * 2014-03-14 2021-10-22 凯尔迪克斯公司 用于在移植受体中监测免疫抑制疗法的方法

Also Published As

Publication number Publication date
DK3004388T3 (en) 2019-02-04
EP3004388B1 (en) 2018-10-31
PL3004388T3 (pl) 2019-04-30
PL3004388T5 (pl) 2023-10-09
LT3004388T (lt) 2019-01-25
PT3004388T (pt) 2019-01-29
HRP20190209T4 (hr) 2023-09-15
EP3004388A4 (en) 2017-01-11
US20220025459A1 (en) 2022-01-27
US20180346982A1 (en) 2018-12-06
DK3004388T4 (da) 2023-08-28
SI3004388T1 (sl) 2019-03-29
WO2014194113A3 (en) 2015-01-22
EP3004388B2 (en) 2023-05-31
US20160115541A1 (en) 2016-04-28
CY1122332T1 (el) 2021-01-27
EP3004388A2 (en) 2016-04-13
WO2014194113A2 (en) 2014-12-04
ES2704682T3 (es) 2019-03-19
US11155872B2 (en) 2021-10-26
HUE041935T2 (hu) 2019-06-28
ES2704682T5 (es) 2023-11-10
HRP20190209T1 (hr) 2019-04-05

Similar Documents

Publication Publication Date Title
HUE041935T2 (hu) Donor sejtmentes DNS-ének detektálása és kvantifikálása a szervtranszplantátumot kapott recipiensek véráramában
HK1220974A1 (zh) 三氟甲基取代的稠合嘧啶類及其用途
IL244296A0 (en) Cell-permeable conjugates and methods of using them
EP2973573A4 (en) APPARATUSES AND METHODS FOR USE IN SELECTING OR ISOLATING MEMORY CELLS
SG11201609118RA (en) Modified natural killer cells and uses thereof
EP2976901A4 (en) DEVICES AND METHOD FOR PROVIDING A MESSAGE REPLY TO DEVICES
SG11201509870QA (en) Culture vessel and culture method
EP3024417A4 (en) GRAFT HAVING AN EXPANDABLE AREA AND METHODS OF MAKING AND USING THE GRAFT
EP2967509A4 (en) COLLECTION AND CONSERVATION OF BIOLOGICAL SAMPLES
HK1219752A1 (zh) 微載體灌注培養方法及其用途
GB201301626D0 (en) Composition comprising 15-OHEPA and methods of using the same
IL249384A0 (en) Methods for producing cells using perfusate and their use
HK1219751A1 (zh) 微載體灌注培養方法及其用途
HK1218247A1 (zh) 益生菌和使用方法
IL245272A0 (en) pif-transfected cells and methods of use
GB201309178D0 (en) Enzyme and uses thereof
GB201403522D0 (en) Improvements in and relating to processed biological sample storage
GB201300346D0 (en) BiologIcal materials and uses thereof
EP3080245A4 (en) Methods for the detection and quantification of circulating endothelial cells
TWI496103B (en) The system and method of sentencing and juries-guiding in taiwan
EP3018134A4 (en) BACTERIA CULTURE MEDIUM AND USE THEREOF
GB201320684D0 (en) An electrochemical sensor and related methods
GB201319273D0 (en) Improvements in structural members and methods relating thereto
GB201423338D0 (en) Slowing aging cell and body RNA
SG11201509554QA (en) Permanent preservation and retrieval of data object in the cloud